COMMUNIQUÉS West-GlobeNewswire

Cara Therapeutics to Announce Second Quarter 2018 Financial Results on August 7, 2018
31/07/2018
STAMFORD, Conn., July 31, 2018 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq:CARA), a clinical-stage biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate [...]
Change in the number of shares and votes in Oasmia Pharmaceutical AB (publ)
31/07/2018
Oasmia Pharmaceutical AB (publ) (”Oasmia”) on the 29 November 2017 issued a convertible loan with a total nominal amount of MSEK 28. In total MSEK 9 of the convertible loan have during July, at the request of [...]
Cellectar Biosciences Announces Closing of $16.56 Million Underwritten Public Offering and Full Exercise of Over-Allotment Option
31/07/2018
MADISON, Wis., July 31, 2018 (GLOBE NEWSWIRE) -- Cellectar Biosciences (Nasdaq: CLRB), a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of [...]
Prothena to Report Second Quarter 2018 Financial Results on August 7
31/07/2018
DUBLIN, Ireland, July 31, 2018 (GLOBE NEWSWIRE) -- Prothena Corporation plc (Nasdaq:PRTA), a clinical-stage neuroscience company, will announce financial results for the second quarter and first six months of 2018 on [...]
Myriad Announces Closing of Counsyl Acquisition
31/07/2018
Transformational Acquisition Enhances Myriad’s Leadership Position in Women’s Health SALT LAKE CITY, July 31, 2018 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a global leader in personalized medicine, [...]
OmniSeq, Inc. to Participate in the NCI-MATCH Clinical Trial
31/07/2018
Having Met Rigorous Qualifications, OmniSeq Becomes One of Several Commercial and Academic Laboratories Designated by the National Cancer Institute to Cast a Wider Net for Patients to Enter the NCI-MATCH Trial BUFFALO, [...]
Zafgen to Host Conference Call to Discuss Second Quarter 2018 Financial Results
31/07/2018
BOSTON, July 31, 2018 (GLOBE NEWSWIRE) -- Zafgen, Inc. (Nasdaq:ZFGN), a clinical-stage biopharmaceutical company leveraging its proprietary knowledge of MetAP2 systems biology to develop novel therapies for patients [...]
Todos Medical, Ltd. Appoints Herman Weiss, MD MBA as New Chief Executive Officer
31/07/2018
REHOVOT, Israel, July 31, 2018 (GLOBE NEWSWIRE) -- Todos Medical Ltd. (OTCQB: TOMDF) ( http://www.Todosmedical.com ) today announced that its Board of Directors has appointed Herman Weiss, MD MBA as the new Chief [...]
Nuvectra™ to Report Second Quarter 2018 Financial Results on August 7, 2018
31/07/2018
PLANO, Texas, July 31, 2018 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced today that it will release its financial results for the second quarter ended [...]
Vital Therapies Announces Upcoming Second Quarter Financial Results Conference Call With Webcast
31/07/2018
SAN DIEGO, July 31, 2018 (GLOBE NEWSWIRE) -- Vital Therapies, Inc. (Nasdaq: VTL), a biotherapeutic company developing ELAD®, a cell-based therapy targeting the treatment of acute forms of liver failure, will release its [...]
Acer Therapeutics Announces Underwritten Public Offering
31/07/2018
NEWTON, Mass., July 31, 2018 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and ultra-rare [...]
NewLink Genetics Announces Clinical Plan, Reports Second Quarter 2018 Financial Results and Revises Cash Guidance
31/07/2018
Management to Host Conference Call Today at 4:30 p.m. ET AMES, Iowa, July 31, 2018 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ:NLNK) today announced its clinical plan and strategy, reported consolidated [...]
Lexicon Pharmaceuticals to Present at Upcoming Investor Conference
31/07/2018
THE WOODLANDS, Texas, July 31, 2018 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that Jeffrey L. Wade, J.D., Executive Vice President, Corporate and Administrative Affairs and Chief [...]
Medtronic Announces 2018 Global Champions Team
31/07/2018
Twenty Runners Representing 13 Countries to Participate in the Medtronic Twin Cities Marathon Weekend This October DUBLIN - July 31, 2018 - This October, 20 runners from 13 different countries around the world will come [...]
Online Availability of Sanofi Group's Half-Year Financial Report for 2018
31/07/2018
Press Release Source: Sanofi (EURONEXT: SAN) (NYSE: SNY) Online Availability of Sanofi Group's Half-Year Financial Report for 2018 PARIS (France) - July 31, 2018 - Sanofi announces that its half-year financial report [...]
Sanofi : Mise en ligne du rapport financier semestriel 2018
31/07/2018
Communiqué de presse Source : Sanofi (EURONEXT: SAN) (NYSE: SNY) Mise en ligne du rapport financier semestriel 2018 Paris (France) - 31 juillet 2018 - Sanofi annonce aujourd'hui avoir mis à la disposition du public et [...]
Sanofi: Disclosure of trading in own shares
31/07/2018
Attachment Disclosure of trading in own shares (pdf).pdf
Sanofi : Déclaration des transactions sur actions propres
31/07/2018
Pièce jointe Déclaration des transactions sur actions propres (pdf).pdf
European Medicines Agency Confirms Accelerated Assessment Procedure for Trogarzo™
31/07/2018
MONTREAL, July 31, 2018 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) is pleased to announce that the Committee for Medicinal Products for Human Use (“CHMP”) of the European Medicines Agency [...]

Pages